Acer Therapeutics Inc (ACER)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
06-2007 | 03-2007 | 12-2006 | 09-2006 | 06-2006 | |
Operating Expenses | 4,624 | 4,146 | 3,470 | 4,000 | 5,180 |
Operating Income | -4,632 | -4,146 | -3,470 | -4,000 | -5,180 |
Interest Expense | 4 | 3 | 1 | 0 | 0 |
Other Income | 150 | 179 | 1,441 | 2,670 | -3,290 |
Pre-tax Income | -4,486 | -3,970 | -2,030 | -1,330 | -8,470 |
Net Income Continuous | -4,486 | -3,970 | -2,030 | -1,332 | -8,475 |
Net Income | $-4,486 | $-3,970 | $-2,030 | $-1,332 | $-8,475 |
EPS Basic Total Ops | -221.95 | -195.45 | -248.45 | -66.25 | -463.77 |
EPS Basic Continuous Ops | -221.88 | -196.36 | -245.66 | -65.94 | -465.66 |
EPS Diluted Total Ops | -221.95 | -195.45 | -248.45 | -66.25 | -463.77 |
EPS Diluted Continuous Ops | -221.88 | -196.36 | -245.66 | -65.94 | -465.66 |
EBITDA(a) | $-4,574 | $-4,097 | $-3,010 | $-3,540 | $-4,720 |